Greenyn Biotechnology Co., Ltd
6846
Rank in Stocks
#23832
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary... Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Share Price
$1.40
Last synced: 2026-11-10
Market Cap
$37.91M
Change (1 day)
-9.01%
Change (1 year)
-43.87%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Greenyn Biotechnology Co., Ltd (6846)
Category
Healthcare
Dividend history for Greenyn Biotechnology Co., Ltd (6846)
Greenyn Biotechnology Co., Ltd (stock symbol: 6846) made a total of 5 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.76
Dividend yield (TTM) : 6.82%
The sum of all dividends (adjusted for stock splits) is : $0.76
Dividend yield (TTM) : 6.82%
Dividend payments for Greenyn Biotechnology Co., Ltd (6846) from 2022 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.12 | 11.87% |
| 2025 | $0.11 | 0.07% |
| 2024 | $0.11 | -14.98% |
| 2023 | $0.13 | -55.56% |
| 2022 | $0.29 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.12 | 11.87% |
| 2025 | $0.11 | 0.07% |
| 2024 | $0.11 | -14.98% |
| 2023 | $0.13 | -55.56% |
| 2022 | $0.29 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
Questions about Greenyn Biotechnology Co., Ltd's dividend per share
What is Greenyn Biotechnology Co., Ltd's dividend per share?
Greenyn Biotechnology Co., Ltd's dividend per share over the last twelve months is $0.12, as of Jun 2026.
What was Greenyn Biotechnology Co., Ltd's dividend per share in 2025?
In 2025, Greenyn Biotechnology Co., Ltd's dividend per share was $0.11, about the same as in 2024 ($0.11).
How has Greenyn Biotechnology Co., Ltd's dividend per share changed since 2022?
From 2022 to 2025, Greenyn Biotechnology Co., Ltd's dividend per share went from $0.29 to $0.11, an average decline of 27.69% a year.